Insiders · AGRX

Sandra Carson

Director at Agile Therapeutics Inc (AGRX)

Sandra Carson has filed 4 insider reports with the SEC since June 2021, as director at Agile Therapeutics Inc (AGRX). The latest filing, on August 26, 2024, reports sale back to the company at Agile Therapeutics Inc (AGRX).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where Sandra Carson is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Agile Therapeutics Inc logo
AGRX
Agile Therapeutics Inc
Director0Aug 26, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Sandra Carson with

Questions about Sandra Carson

What is Sandra Carson's role at Agile Therapeutics Inc?
Sandra Carson reports to the SEC as director at Agile Therapeutics Inc (AGRX), according to the latest filing on August 26, 2024.
Has Sandra Carson bought or sold stock recently?
No open-market purchases or sales by Sandra Carson are on file. The filings report sale back to the company and grant or award.
How do I get alerts when Sandra Carson files?
Follow Sandra Carson on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Sandra Carson (SEC CIK 0001813742). Totals count each trade once, skipping amendments whose original is on file, from Jun 11, 2021 on. View on SEC EDGAR